Related Experiment Video
Updated: Jul 12, 2025
08:07
Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line
Published on: February 17, 2016
72.4K
Polyomavirus Wakes Up and Chooses Neurovirulence.
Arrienne B Butic1, Samantha A Spencer1, Shareef K Shaheen1
1Department of Microbiology and Immunology, Penn State College of Medicine, Hershey, PA 17033, USA.
Viruses
|October 28, 2023
Summary
JC polyomavirus (JCPyV) causes severe CNS disease in immunocompromised individuals. The mouse polyomavirus (MuPyV) model offers insights into JCPyV pathogenesis and potential therapeutic strategies.
Area of Science:
- Virology
- Immunology
- Neurology
Background:
- JC polyomavirus (JCPyV) establishes lifelong infections, primarily in the urinary tract.
- Immunocompromised states allow JCPyV to invade the central nervous system (CNS), causing fatal encephalopathies like progressive multifocal leukoencephalopathy (PML).
- Current treatments for JCPyV-induced CNS disease are lacking.
Purpose of the Study:
- To explore the pathogenesis of JCPyV CNS infection.
- To understand JCPyV migration from peripheral organs to the CNS.
- To evaluate the utility of the mouse polyomavirus (MuPyV) model for studying JCPyV CNS disease.
Main Methods:
- Review of existing literature on JCPyV and MuPyV infections.
- Analysis of immune responses to polyomavirus infections.
- Comparative study of JCPyV in humans and MuPyV in mice.
Main Results:
- JCPyV reactivation in the urinary tract is linked to immune suppression.
- Mechanisms of JCPyV viremia and CNS entry remain incompletely understood.
- The MuPyV-mouse model shares key features with human JCPyV infection, aiding pathogenesis research.
Conclusions:
- The MuPyV-mouse model is a valuable tool for investigating JCPyV CNS disease.
- Further research is needed to elucidate JCPyV's neuroinvasive pathways.
- Understanding these mechanisms is crucial for developing effective anti-JCPyV therapeutics.
